SEMGLEE
NDC 83257-011, insulin glargine-yfgn, injection, solution, from Biocon Biologics Inc..
- Product NDC
- 83257-011
- Status
- Listed
- Labeler
- Biocon Biologics Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761201
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83257-011 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- INSULIN GLARGINE100 [iU]/mL
Pharmacologic classes
Insulin Analog [EPC]; Insulin [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83257-011-11 | 83257001111 | 1 VIAL, MULTI-DOSE in 1 CARTON (83257-011-11) / 10 mL in 1 VIAL, MULTI-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/8cf5544f-87d6-468b-f6ae-898b1fdb5d80NADAC price for package 83257001111
GET /v1/drugs/nadac/83257001111
Use it
Look up 83257-011 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83257-011 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83257-011. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.